| View |
|
DRP-089
|
Ramipril
|
Tritace
|
2.5 mg
|
Tablet
|
Angiotensin-Converting Enzyme (ACE) Inhibitor
|
PT Aventis Farma
|
Indonesia
|
CLIDP Conversion
|
12 August 2024
|
27 October 2029
|
| View |
|
DRP-1077-22
|
Co-Amoxiclav
|
Comxicare 625
|
625 mg
|
Tablet
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
11 August 2024
|
07 October 2028
|
| View |
|
DRP-10892-07
|
Zoledronic acid (as monohydrate)
|
Zolentra
|
800 mcg / mL (4 mg / 5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
Bisphosphonate
|
Aroma Ilac San. Ltd. Sti
|
Turkey
|
CLIDP Conversion
|
11 August 2024
|
14 December 2026
|
| View |
|
DRP-1092-14
|
Co-Amoxiclav
|
Orcomox-S
|
312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
12 August 2024
|
14 October 2028
|
| View |
|
DRP-11397-02
|
Vancomycin
|
Vancomeed
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Glycopeptide)
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
18 August 2024
|
08 March 2027
|
| View |
|
DRP-11851-12
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Zyrluxe
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
18 August 2024
|
10 May 2027
|
| View |
|
DRP-12201-05
|
Rosuvastatin (as calcium)
|
Jivastatin
|
10 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
12 August 2024
|
29 June 2027
|
| View |
|
DRP-12424-06
|
Omeprazole (as sodium monohydrate)
|
Amkomep
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
18 August 2024
|
04 August 2027
|
| View |
|
DRP-1252-08
|
Paracetamol + Phenylephrine Hydrochloride + Dextromethorphan Hydrobromide
|
Flunasin
|
325 mg/ 25 mg/ 10 mg
|
Capsule
|
Analgesic/Antipyretic/Nasal Decongestant/Antitussive
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 August 2024
|
20 August 2028
|
| View |
|
DRP-12623-02
|
Trimetazidine Hydrochloride
|
Trimezen
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
11 August 2024
|
29 November 2026
|
| View |
|
DRP-12623-05
|
Trimetazidine Hydrochloride
|
Trimestat
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 August 2024
|
29 November 2026
|
| View |
|
DRP-12808-03
|
Amlodipine (as Besilate) + Hydrochlorothiazide
|
Amlomel Plus
|
5 mg / 12.5 mg
|
Tablet
|
Calcium Channel Blocker and Diuretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
12 August 2024
|
28 October 2027
|
| View |
|
DRP-13079-01
|
Guaifenesin + Bromhexine Hydrochloride + Salbutamol (as Sulfate)
|
Asfrenon-BR
|
100 mg/ 4 mg/ 2 mg per 10 mL
|
Syrup
|
Expectorant / Mucolytic / Bronchodilator
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 August 2024
|
25 November 2029
|
| View |
|
DRP-13127-13
|
Ketoanalogues + Essential Amino Acids
|
Ketourea
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 August 2024
|
05 December 2027
|
| View |
|
DRP-13127-14
|
Ketoanalogues + Essential Amino Acids
|
Neprotect
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 August 2024
|
05 December 2027
|
| View |
|
DRP-13338-02
|
Parecoxib (as sodium)
|
Projexib
|
40 mg
|
Lyophilized Powder for Injection (IM/IV)
|
Selective Cox-2 lnhibitor (Coxib)
|
Wanbang Biopharmaceuticals
|
China
|
CLIDP Conversion
|
12 August 2024
|
30 January 2028
|
| View |
|
DRP-13517-04
|
Levetiracetam
|
Seiletam
|
500 mg
|
Film-Coated Tablet
|
Anticonvulsant
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 August 2024
|
03 March 2028
|
| View |
|
DRP-13687-07
|
Losartan Potassium
|
Spartan 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 August 2024
|
28 March 2028
|
| View |
|
DRP-13689-03
|
Ceftazidime (as pentahydrate)
|
None
|
1 g
|
Powder for Injection (IV/IM)
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
15 August 2024
|
05 March 2029
|
| View |
|
DRP-14019-06
|
Co-Amoxiclav
|
Comxicare-S
|
457 mg/ 5mL
|
Powder for Suspension
|
Antibacterial (Penicillins)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
18 August 2024
|
06 June 2028
|